Case review: Genomic testing in a man with high-grade, high-risk prostate cancer.

An interview with case review panelists Jason M. Hafron, Rachelle Manookian and Kerry Schaffer regarding the case of a high-grade, high-risk prostate cancer patient is presented. When asked about his view on genomic testing in the present case considering their protocols at Michigan Institute of Urology, Hafron states that they have taken an in-depth approach to genomic and somatic testing. Schaffer also explains their protocol for patients with the same case who mentions germline testing.